Table 2

‚ÄÉChanges in TDS, H/M ratio, and WR of patients in valsartan and enalapril groups

ValsartanEnalapril
Baseline6 monthsBaseline6 months
Values are mean (SD).
*p<0.01 v baseline; **p<0.05 v baseline.
123I-MIBG
TDS43 (8)39 (10)*43 (9)42 (10)
H/M ratio1.70 (0.17)1.78 (0.22)**1.68 (0.36)1.67 (0.22)
WR46 (11)41 (10)**47 (8)46 (10)